KORU Medical Systems (KRMD)

• Market cap: $105M
• 1 day: -0.87%
• 5 days: -0.44%
• 1 month: -23.57%
• 3 months: -44.50%
• 6 months: -10.98%
• Year to date: -41.65%
• 1 year: 7.08%
• 5 years: -79.12%
• 10 years: -42.82%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Employees: 80

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

90% more capital invested

Capital invested by funds: $34.9M [Q3] → $66.1M (+$31.3M) [Q4]

19% more funds holding

Funds holding: 54 [Q3] → 64 (+10) [Q4]

9.65% more ownership

Funds ownership: 27.85% [Q3] → 37.5% (+9.65%) [Q4]

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

73% less call options, than puts

Call options by funds: $12K | Put options by funds: $45K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $4.50 98% upside
• Avg. target: $4.50 98% upside
• High target: $4.50 98% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Piper Sandler Jason Bednar 17% 1-year accuracy 6 / 35 met price target

98% upside $4.50

Neutral Downgraded

14 Feb 2025